Thrombolytic Administration for Acute Ischemic Stroke
Background: The therapeutic benefit of tissue plasminogen activator (tPA) for acute ischemic stroke is provenbut extremely time-dependent. Current guidelines recommend a <60 minute door-to-needle time. We identify here factors affecting door-to-needle time of tPA administration for acute ischemi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
McGill University
2022-03-01
|
Series: | McGill Journal of Medicine |
Subjects: | |
Online Access: | https://mjm.mcgill.ca/article/view/881 |